[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595628":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":53,"collaborators":20,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":20,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":37,"whyStopped":20,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"LLC UkrMedGroup","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Participant Group\u002FArm","EXPERIMENTAL","Participants in this arm will receive standard postpartum hemorrhage (PPH) management followed by application of the Abdominal Aortic and Junctional Tourniquet - Stabilized (AAJT-S) device if bleeding remains uncontrolled after uterotonics and uterine balloon tamponade. The device will be applied to the upper abdomen and inflated to 250 mmHg to achieve temporary aortic occlusion for up to 60 minutes. The intervention is intended to temporize bleeding while definitive surgical treatment and blood transfusion are arranged.",[13],"Device: Abdominal Aortic and Junctional Tourniquet - Stabilized (AAJT-S)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Abdominal Aortic and Junctional Tourniquet - Stabilized (AAJT-S)","The AAJT-S is a non-invasive, externally applied medical device designed to achieve temporary occlusion of the abdominal aorta and inferior vena cava by inflating a pneumatic bladder to 250 mmHg. In this study, the device will be used as a temporizing measure for patients with severe postpartum hemorrhage unresponsive to standard uterotonics and balloon tamponade. The device will be applied horizontally over the upper abdomen and inflated using a built-in pressure gauge. The intended effect is to reduce pelvic blood flow and allow time for mobilization of surgical resources and blood transfusion. Maximum application time will not exceed 60 minutes, in accordance with established safety guidelines.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Yevheniia Poliakova, Ph.D","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","+380502818399","jenyapolyakova@gmail.com",{"name":31,"role":27,"phone":32,"phoneExt":20,"email":33},"Viktor Oshovskyy, DMSc, PhD","+380991770303","pirhospr@gmail.com",[35],{"facility":36,"status":37,"city":38,"state":20,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Olexandrivska Hospital","RECRUITING","Zaporizhzhia","69000","Ukraine","UA",{"type":43,"coordinates":44},"Point",[45,46],35.74246,47.15214,{"lat":46,"lon":45},[49,51,52],{"name":50,"role":27,"phone":28,"phoneExt":20,"email":29},"Yevheniia Poliakova, PhD",{"name":31,"role":27,"phone":32,"phoneExt":20,"email":33},{"name":50,"role":24,"phone":20,"phoneExt":20,"email":20},{"type":54,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100595628","temporary-aortic-compression-with-the-abdominal-tourniquet-for-refractory-postpartum-hemorrhage-100595628",false,"NCT07034924","Temporary Aortic Compression With the Abdominal Tourniquet for Refractory Postpartum Hemorrhage","ACT-PPH","Inclusion Criteria:\n\n* Age ≥18 years\n* Clinical diagnosis of postpartum hemorrhage (PPH) refractory to uterotonics and intrauterine balloon tamponade\n* Estimated blood loss greater than 1300 mL\n* Oral informed consent provided prior to device application\n\nExclusion Criteria:\n\n* Patients with postpartum bleeding as a result of trauma, retained placenta or coagulopathy were excluded","FEMALE","18 Years","50 Years",{"count":66,"type":67},20,"ESTIMATED","INTERVENTIONAL",[70],"NA","This multicenter study aims to evaluate effectiveness and safety of using the AAJT-S device as a temporary intervention for severe, atony-related PPH that is refractory to standard therapies",[73],"Postpartum Hemorrhage",[75],"postpartum hemorrhage","2025-10-02",{"date":78,"type":79},"2025-10-07","ACTUAL",{"date":81,"type":79},"2025-07-01",{"date":83,"type":67},"2026-07",{"name":5,"class":6},1]